Palisades Hudson Asset Management’s Gilead Sciences GILD Stock Holding History

Palisades Hudson Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Hold	1,792	–	–	0.08%	102
2026 Q1	$249K	Hold	1,792	–	–	0.1%	89
2025 Q4	$220K	Buy	+1,792	New	+$218K	0.09%	95
2025 Q2	–	Sell	-1,792	Closed	-$201K	–	111
2025 Q1	$201K	Buy	+1,792	New	+$185K	0.09%	97
2020 Q3	–	Sell	-2,960	Closed	-$228K	–	97
2020 Q2	$228K	Hold	2,960	–	–	0.16%	82
2020 Q1	$221K	Buy	+2,960	New	+$205K	0.19%	73
2019 Q1	–	Sell	-3,790	Closed	-$237K	–	104
2018 Q4	$237K	Hold	3,790	–	–	0.14%	96
2018 Q3	$293K	Hold	3,790	–	–	0.15%	91
2018 Q2	$268K	Hold	3,790	–	–	0.14%	91
2018 Q1	$286K	Hold	3,790	–	–	0.16%	88
2017 Q4	$272K	Hold	3,790	–	–	0.15%	91
2017 Q3	$307K	Hold	3,790	–	–	0.17%	79
2017 Q2	$268K	Hold	3,790	–	–	0.16%	92
2017 Q1	$257K	Hold	3,790	–	–	0.16%	83
2016 Q4	$271K	Hold	3,790	–	–	0.17%	75
2016 Q3	$300K	Hold	3,790	–	–	0.23%	64
2016 Q2	$316K	Hold	3,790	–	–	0.26%	60
2016 Q1	$348K	Hold	3,790	–	–	0.27%	52
2015 Q4	$384K	Hold	3,790	–	–	0.32%	43
2015 Q3	$372K	Hold	3,790	–	–	0.33%	41
2015 Q2	$443K	Hold	3,790	–	–	0.38%	35
2015 Q1	$372K	Hold	3,790	–	–	0.29%	46
2014 Q4	$357K	Hold	3,790	–	–	0.28%	53
2014 Q3	$403K	Hold	3,790	–	–	0.33%	36
2014 Q2	$314K	Hold	3,790	–	–	0.26%	44
2014 Q1	$269K	Hold	3,790	–	–	0.23%	54
2013 Q4	$285K	Hold	3,790	–	–	0.24%	51
2013 Q3	$238K	Buy	+3,790	New	+$227K	0.21%	53

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Palisades Hudson Asset Management's GILD Position: Q2 2026 in Review

Palisades Hudson Asset Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,792 shares worth $226K. The position accounts for 0.08% of the portfolio, ranked #102.

Palisades Hudson Asset Management first reported a position in GILD in Q3 2013 and has held it in 28 quarters since. The position peaked at $443K in Q2 2015. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Palisades Hudson Asset Management held 1,792 shares of Gilead Sciences worth $226K as of Q2 2026.
Palisades Hudson Asset Management left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.08% of Palisades Hudson Asset Management's portfolio in Q2 2026, its #102 holding.
Palisades Hudson Asset Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 28 quarters since.
Palisades Hudson Asset Management's Gilead Sciences position peaked at $443K in Q2 2015.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Palisades Hudson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.